Early research (Phase 1)Study completedNCT03000257What this trial is testingBudigalimab (ABBV-181) in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 182
Early research (Phase 1)Ended earlyNCT02936102What this trial is testingFAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.Who this might be right forAdvanced Solid TumorsTriple Negative Breast CancerChordoma and Alveolar Soft Part Sarcoma Novartis Pharmaceuticals 154
Testing effectiveness (Phase 2)Study completedNCT03092934What this trial is testingAK-01 (LY3295668) in Solid TumorsWho this might be right forNeoplasmsNeoplasm MetastasisTriple Negative Breast Neoplasms+4 more Eli Lilly and Company 13
Early research (Phase 1)Study completedNCT05585034What this trial is testingPhase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid TumorsWho this might be right forHead and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more Xencor, Inc. 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03090165What this trial is testingRibociclib and Bicalutamide in AR+ TNBCWho this might be right forTriple Negative Breast Cancer Kari Wisinski 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07080619What this trial is testingSC-101 in Subjects With Advanced NECTIN4-Amplified CancersWho this might be right forTNBC - Triple-Negative Breast CancerHR+ Breast Cancer Tianjin ConjuStar Biologics Co., Ltd. 120
Early research (Phase 1)Active Not RecruitingNCT03893955What this trial is testingDetermine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forCancerAdvanced Solid TumorsTriple-Negative Breast Cancer (TNBC)+2 more AbbVie 150
Early research (Phase 1)Study completedNCT03251378What this trial is testingA Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast CancersWho this might be right forAdvanced Solid TumorsMetastatic Colon CancerMetastatic Breast Cancer+4 more Hutchison Medipharma Limited 129
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07359404What this trial is testingSacituzumab Govitecan Plus Bevacizumab in Metastatic TNBCWho this might be right forAdvanced Breast Cancer YING FAN 60
Early research (Phase 1)Active Not RecruitingNCT02792114What this trial is testingT-Cell Therapy for Advanced Breast CancerWho this might be right forBreast CancerMetastatic HER2-negative Breast Memorial Sloan Kettering Cancer Center 186
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Looking for participantsNCT06586957What this trial is testingA Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorAdvanced Solid TumorSolid Tumor, Adult+25 more NiKang Therapeutics, Inc. 150
Early research (Phase 1)Study completedNCT03538028What this trial is testingA Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesWho this might be right forCervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more Incyte Biosciences International Sàrl 22
Early research (Phase 1)Looking for participantsNCT06799065What this trial is testingFirst-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian CancerWho this might be right forAdvanced Solid TumorsBreast Cancer RecurrentOvarian Cancer+2 more Accent Therapeutics 90
Early research (Phase 1)Ended earlyNCT03292172What this trial is testingEvaluate the Safety, Pharmacokinetics and Clinical Activity of RO6870810 and Atezolizumab (PD-L1 Antibody) in Participants With Advanced Ovarian Cancer or Triple Negative Breast CancerWho this might be right forAdvanced Ovarian CancerTriple Negative Breast Cancer Hoffmann-La Roche 36
Testing effectiveness (Phase 2)Looking for participantsNCT06636981What this trial is testingAll Trans Retinoic Acid Combined with Toripalimab+Chemotherapy for Locally Advanced Inoperable or Metastatic Triple Negative Breast Cancer：a Multi-center, Multi-cohort Phase II TrialWho this might be right forTriple Negative Breast Cancer (TNBC) Fudan University 129
Testing effectiveness (Phase 2)Study completedNCT00930930What this trial is testingCisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast CancerWho this might be right forBreast Cancer Vanderbilt-Ingram Cancer Center 145
Not applicableNot Yet RecruitingNCT07191405What this trial is testingClinical Study of Chemotherapy and Immunotherapy Combined With Lactobacillus Johnsonii in Patients With Multiple Irresectable Solid TumorsWho this might be right forImmunotherapyChemotherapy Second Affiliated Hospital, School of Medicine, Zhejiang University 156
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07134556What this trial is testingPhase II Trial Evaluating the Safety and Efficacy of the Combination of Zimberelimab, Domvanalimab and Sacituzumab Govitecan as 1L Therapy for PD-L1 Positive Advanced TNBCWho this might be right forTriple Negative Breast CancerPDL-1 Positive MedSIR 25
Testing effectiveness (Phase 2)UnknownNCT04395989What this trial is testingAn Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC.Who this might be right forTNBC - Triple-Negative Breast Cancer Fudan University 139